Novo A/S
Latest statistics and disclosures from Novo Holdings A/S's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VTI, Inogen, Cable One, AAPL, BAM.A, and represent 81.19% of Novo Holdings A/S's stock portfolio.
- Added to shares of these 10 stocks: VTI (+$188.88M), BAM.A (+$40.55M), AAPL (+$35.55M), Cable One (+$17.51M), Myokardia (+$5.69M), Constellation Pharmceticls I (+$5.29M), Zogenix, Blueprint Medicines, Seaspine Holdings, Akebia Therapeutics.
- Started 1 new stock positions in Constellation Pharmceticls I.
- Reduced shares in these 3 stocks: Silk Road Medical Inc Common, Inspire Med Sys Inc, Milestone Pharmaceuticals Inc.
- Novo Holdings A/S was a net buyer of stock by $311.94M.
- Novo Holdings A/S has $1.50B in assets under management (AUM), dropping by -3.50%.
Portfolio Holdings for Novo Holdings A/S
Companies in the Novo Holdings A/S portfolio as of the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Vanguard Total Stock Market ETF (VTI) | 49.82 | 5.79M | +33% | 128.91 |
| Inogen | 12.24 | 3.55M | 51.66 | |
| Cable One | 8.18 | 74595 | +16% | 1644.01 |
| Apple (AAPL) | 6.92 | 407606 | +52% | 254.29 |
| Brookfield Asset Management (BAM.A) | 4.03 | 2.05M | +204% | 29.50 |
| Morphic Hldg Inc Com | 2.59 | 2.65M | 14.68 | |
| Mirum Pharmaceuticals Inc | 2.28 | 2.45M | 14.00 | |
| Galera Therapeutics Inc | 2.16 | 3.41M | 9.50 | |
| Akebia Therapeutics | 1.72 | 3.39M | +9% | 7.58 |
| Amicus Therapeutics (FOLD) | 1.43 | 2.32M | 9.24 | |
| Seaspine Holdings | 0.94 | 1.72M | +31% | 8.17 |
| Blueprint Medicines | 0.91 | 234267 | +37% | 58.48 |
| Si-bone | 0.77 | 971390 | +8% | 11.95 |
| Aerie Pharmaceuticals | 0.68 | 750974 | +12% | 13.50 |
| Inspire Med Sys Inc | 0.62 | 154622 | -11% | 60.28 |
| Spero Therapeutics Inc | 0.50 | 931099 | 8.08 | |
| Myokardia | 0.47 | 151816 | +400% | 46.88 |
| Corvus Pharmaceuticals | 0.41 | 2.93M | 2.11 | |
| Silk Road Medical Inc Common | 0.39 | 186042 | -24% | 31.48 |
| Entasis Therapeutics Holdings Ord | 0.38 | 2.18M | 2.64 | |
| Zogenix | 0.37 | 223184 | +525% | 24.73 |
| Constellation Pharmceticls I | 0.35 | 168381 | NEW | 31.43 |
| Flexion Therapeutics convertible security | 0.34 | 643370 | +42% | 7.87 |
| Protagonist Therapeutics Inc Com stock | 0.33 | 697899 | +45% | 7.06 |
| Intersect Ent | 0.29 | 370595 | +70% | 11.85 |
| Milestone Pharmaceuticals Inc | 0.26 | 2.08M | -14% | 1.84 |
| Verona Pharma Plc ads | 0.20 | 740740 | 4.12 | |
| Crinetics Pharmaceuticals In | 0.16 | 164453 | +21% | 14.70 |
| Biohaven Pharmaceutical Holding | 0.12 | 54100 | +50% | 34.03 |
| Neuronetics Inc | 0.11 | 902872 | +22% | 1.89 |
Download CSV 
Past Filings by Novo Holdings A/S
View past SEC 13F filings by Novo Holdings A/S
- Novo Holdings A/S 2019 Q4 filed Feb. 14, 2020
- Novo Holdings A/S 2019 Q3 filed Nov. 14, 2019
- Novo Holdings A/S 2019 Q1 filed May 15, 2019
- Novo Holdings A/S 2018 Q4 filed Feb. 14, 2019
- Novo Holdings A/S 2018 Q2 amended filed Feb. 6, 2019
- Novo Holdings A/S 2018 Q3 amended filed Feb. 6, 2019
- Novo Holdings A/S 2018 Q3 filed Nov. 14, 2018
- Novo Holdings A/S 2018 Q2 filed Aug. 14, 2018
- Novo Holdings A/S 2018 Q1 filed May 15, 2018
- Novo Holdings A/S 2017 Q4 filed Feb. 14, 2018
- Novo Holdings A/S 2017 Q3 filed Nov. 14, 2017
- Novo Holdings A/S 2017 Q2 filed Aug. 14, 2017
- Novo A/S 2017 Q1 filed May 15, 2017
- Novo A/S 2016 Q4 filed Feb. 14, 2017
- Novo A/S 2016 Q3 filed Nov. 14, 2016
- Novo A/S 2016 Q2 filed Aug. 15, 2016
- Novo A/S 2016 Q1 filed May 16, 2016
- Novo A/S 2015 Q4 filed Feb. 16, 2016